Peabody, MA, United States of America

Joseph Arndt

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Peabody, MA (US) (2017 - 2018)
  • Swampscott, MA (US) (2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Joseph Arndt: A Pioneer in Antibody Innovations

Introduction

Joseph Arndt, an inventive mind based in Peabody, Massachusetts, is recognized for his significant contributions to the field of biotechnology. With a total of five patents, he has been instrumental in developing groundbreaking therapies through innovative antibodies, focusing primarily on treating conditions such as multiple sclerosis and epilepsy.

Latest Patents

One of Arndt's latest patents is the "Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibody." This invention provides novel dipeptide repeat-specific antibodies, including human-derived variants. These antibodies are capable of binding to C9orf72 poly-glycine-alanine DPRs, paving the way for new pharmaceutical and diagnostic compositions aimed at DPR protein-targeted immunotherapy and diagnostics.

Another noteworthy patent is related to "Anti-VLA-4 antibodies having reduced effector function." This invention encompasses anti-VLA-4 antibodies and their binding fragments, along with polynucleotides encoding these antibodies. The developments enable methods for treating patients with multiple sclerosis and epilepsy, offering reduced susceptibility to scrambling of recombinant anti-alpha 4 antibodies or their binding fragments.

Career Highlights

Arndt’s professional journey includes significant roles at Biogen MA Inc. and Sunesis Pharmaceuticals, Inc., where he has contributed his expertise in antibody research and development. His work has led to advancements that have potential benefits for patients suffering from serious neurological conditions.

Collaborations

Throughout his career, Joseph has collaborated with notable scientists, including Deping Wang and Timothy Raymond Chan. These partnerships have fostered an environment of innovation and discovery, driving forward the field of antibody therapeutics.

Conclusion

Joseph Arndt continues to push the boundaries of antibody research, making impactful contributions through his patents and collaborative efforts. His work stands as a testament to the importance of innovation in biotechnology, aiming to improve the lives of countless individuals affected by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…